Societal Impact of Research Funding for Women's Health in Alzheimer's Disease and Alzheimer's Disease–Related Dementias
Apr 22, 2021
Women's health has suffered from insufficient research addressing women. The research community has not widely embraced the value of this research. The impact of limited knowledge about women's health relative to men's is far reaching. Without information on the potential return on investment for women's health research, research funders, policymakers, and business leaders lack a basis for altering research investments to improve knowledge of women's health.
Research impact analysis is a framework for supporting decision making about research funding allocation. Economic modeling aids with such impact analysis. Microsimulation models provide a method of quantifying the potential future impact of additions to research investment. Using microsimulation analyses, we examined the societal cost impact of increasing research funding in Alzheimer's Disease and Alzheimer's Disease related disorders (AD/ADRD). We quantified the potential impact of increasing funding on women's health on health outcomes and ultimate societal costs including healthcare expenditures, labor productivity of informal caregivers, and quality-adjusted life years (QALYs). We calculated impacts across 30 years of two funding scenarios: doubling the current 12 percent of the National Institutes of Health extramural AD/ADRD portfolio devoted to women's health and tripling that investment. Impact of a current investment was assumed to occur in 10 years, with benefits accruing after that.